rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Dana Boyle

Chief Accounting Officer

Company insider

Files Form 4 as: Chief Accounting Officer, Liquidia.

Every Form 4 they filed

In numbers

Trades disclosed
44
Buys
0
Sells
15
Bought
$0
Sold
$4.1M
Companies
1
Companies where not an officer
0
First trade
1 Jul 2025
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
LQDA LiquidiaOfficer · Biotechnology · last 12 Oct 20260 buys · 15 sells

Activity over time

1 Jul 2025 – 1 Oct 2026
20Jul 25Nov 25Mar 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$168K5,892 at $28.48filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,178filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,178 at $0.00filing
27 Jul 2026filed 29 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$140K1,600 at $87.53filing
27 Jul 2026filed 29 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$140K1,600 at $87.53filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$46K641 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$598K8,361 at $71.52filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$46K641 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$598K8,361 at $71.52filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,179filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,179 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,179 at $0.00filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,179filing
27 Apr 2026filed 29 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$60K1,576 at $37.78filing
27 Apr 2026filed 29 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$60K1,576 at $37.78filing
13 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$196K5,101 at $38.37filing
13 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$196K5,101 at $38.37filing
10 Apr 2026filed 14 Apr 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,179filing
10 Apr 2026filed 14 Apr 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,179 at $0.00filing
10 Apr 2026filed 14 Apr 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,179 at $0.00filing

Sectors

Health Care15

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Rajeev SaggarChief Medical Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days
Sarah KreppChief Human Resource Officer · Also traded LQDA in the last 90 days